Zydus Lifesciences Limited has announced the launch of its Semaglutide injection in India under the brand names SEMAGLYN, MASHEMA, and ALTERME, following the expiry of the product’s patent.
.png)
DrStore Healthcare Services, a connected healthcare and medical device ecosystem company, through its smart medical devices and tech platform Tracky, has launched an integrated, real-time monitoring platform designed to track patient...
Novartis is preparing to share new clinical findings at the American Academy of Dermatology (AAD) Annual Meeting 2026, focusing on treatments for chronic skin conditions and how patients respond over time.
Pfizer and Valneva have shared encouraging results from a late-stage clinical trial of their Lyme disease vaccine, offering new hope in the fight against a growing health concern.
Glenmark Pharmaceuticals has launched its new diabetes drug, Glipiq, in India, with a clear focus on making advanced treatment more affordable and accessible. The move comes as the country continues to see a sharp rise in type 2 diabetes, placin...
India’s push to lead in gene therapy clinical progress took center stage in Parliament today as officials from the government detailed how the country is advancing cutting edge treatments while relying on a firm regulatory system.
Lupin Manufacturing Solutions announces the expansion of its Dabhasa facility to enhance peptide and CRDMO capabilities, supporting global demand for complex therapeutics and drug development.
Akums Drugs & Pharmaceuticals has launched Lasmiditan dispersible tablet aimed at providing faster and easier relief during acute migraine attacks.
Merck reveals new clinical data on heart and lung diseases at ACC.26, showcasing promising treatments for high cholesterol and heart failure, offering hope for millions.
.png)
Zydus Lifesciences Limited and Torrent Pharmaceuticals Limited today announced a licensing and supply agreement to co market semaglutide injection in India.
, CDSCO.jpg)